Filing Details
- Accession Number:
- 0001104659-25-002054
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-08 16:32:30
- Reporting Period:
- 2025-01-06
- Accepted Time:
- 2025-01-08 16:32:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1736243 | Acurx Pharmaceuticals Inc. | ACXP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1319892 | C Joseph Scodari | C/O Acurx Pharmaceuticals, Inc., 259 Liberty Avenue Staten Island NY 10305 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-01-06 | 24,631 | $1.02 | 27,708 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrants for Common Stock | Acquisiton | 2025-01-06 | 24,631 | $0.00 | 24,631 | $0.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 24,631 | 2025-01-07 | 2030-01-07 | No | 4 | P | Direct |
Footnotes
- Acquired at the offering price in a registered direct offering of common stock by Acurx Pharmaceuticals, Inc.
- Acquired in a concurrent private placement of warrants by Acurx Pharmaceuticals, Inc. in connection with the registered direct offering of common stock.
Billionaire Hedge Funds
